These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8262056)

  • 1. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation.
    Kruse N; Shen BJ; Arnold S; Tony HP; Müller T; Sebald W
    EMBO J; 1993 Dec; 12(13):5121-9. PubMed ID: 8262056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.
    Kruse N; Tony HP; Sebald W
    EMBO J; 1992 Sep; 11(9):3237-44. PubMed ID: 1387082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4.
    Reusch P; Arnold S; Heusser C; Wagner K; Weston B; Sebald W
    Eur J Biochem; 1994 Jun; 222(2):491-9. PubMed ID: 7517357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells.
    Fanslow WC; Spriggs MK; Rauch CT; Clifford KN; Macduff BM; Ziegler SF; Schooley KA; Mohler KM; March CJ; Armitage RJ
    Blood; 1993 Jun; 81(11):2998-3005. PubMed ID: 8499634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
    Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
    J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.
    Zurawski SM; Vega F; Huyghe B; Zurawski G
    EMBO J; 1993 Jul; 12(7):2663-70. PubMed ID: 8101483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency.
    Tony HP; Shen BJ; Reusch P; Sebald W
    Eur J Biochem; 1994 Oct; 225(2):659-65. PubMed ID: 7957181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic mutant proteins of interleukin-4.
    Duschl A; Müller T; Sebald W
    Behring Inst Mitt; 1995 Jun; (96):87-94. PubMed ID: 7575356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain.
    Wang Y; Shen BJ; Sebald W
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1657-62. PubMed ID: 9050834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor.
    Harada N; Yang G; Miyajima A; Howard M
    J Biol Chem; 1992 Nov; 267(32):22752-8. PubMed ID: 1429625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
    Wang HY; Zamorano J; Keegan AD
    J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation.
    Cosenza L; Rosenbach A; White JV; Murphy JR; Smith T
    Protein Sci; 2000 May; 9(5):916-26. PubMed ID: 10850801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the interleukin-4 receptor alpha chain with p47phox, an activator of the phagocyte NADPH oxidase in B cells.
    Izuhara K; Arinobu Y; Sumimoto H; Nunoi H; Takeya R; Higuchi K; Takeshige K; Hamasaki N; Harada N
    Mol Immunol; 1999 Jan; 36(1):45-52. PubMed ID: 10369419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
    Reichel M; Nelson BH; Greenberg PD; Rothman PB
    J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain.
    Letzelter F; Wang Y; Sebald W
    Eur J Biochem; 1998 Oct; 257(1):11-20. PubMed ID: 9799097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circularly permuted interleukin 4 retains proliferative and binding activity.
    Kreitman RJ; Puri RK; McPhie P; Pastan I
    Cytokine; 1995 May; 7(4):311-8. PubMed ID: 8589260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.
    Solari R; Quint D; Obray H; McNamee A; Bolton E; Hissey P; Champion B; Zanders E; Chaplin A; Coomber B
    Biochem J; 1989 Sep; 262(3):897-908. PubMed ID: 2590174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.